Karuna Therapeutics Total Non Current Liabilities 2011-2026 | KRTX

Annual Total Non Current Liabilities Karuna Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	150 K	102 K	3.99 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.99 M	102 K	1.41 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Aptorum Group Limited APM	2.21 M	$ 0.83	2.17 %	$ 4.53 M	China
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	131 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
BioNTech SE BNTX	341 M	$ 110.14	3.3 %	$ 27.2 B	Germany
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Adagene ADAG	158 M	$ 2.6	-1.12 %	$ 146 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.51	-0.52 %	$ 8.45 B	Australia
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 4.21	1.2 %	$ 9.16 B	Israel
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	168 M	$ 1.49	7.19 %	$ 279 M	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Ascendis Pharma A/S ASND	101 M	$ 221.8	-0.16 %	$ 5 B	Danmark
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.46	2.46 %	$ 373 M	Britain
Amneal Pharmaceuticals AMRX	2.42 B	$ 14.49	-0.24 %	$ 4.48 B	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.35	-1.81 %	$ 14.8 M	USA
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA